pharmaphorum

FDA clears first DTx for depression from Otsuka, Click

Otsuka and Click Therapeutics’ Rejoyn has become the first prescription digital therapeutic (DTx) to be approved by the FDA for people with major depressive disorder. Rejoyn (formerly CT-152), a ...
GitHub

Data Structures and Algorithms in JavaScript

This is the coding implementations of the DSA.js book and the repo for the NPM package. In this repository, you can find the implementation of algorithms and data structures in JavaScript. This ...
GitHub

Google Closure Compiler

The Closure Compiler is a tool for making JavaScript download and run faster. It is a true compiler for JavaScript. Instead of compiling from a source language to machine code, it compiles from ...
Windows Report

Broken Image Icon: What Does It Mean & How to Fix It

Google Chrome is a great browser, but some users experienced a broken image icon, rendering websites unusable. If many pages open in Chrome without images, switch on ...

From XSS to RCE: How to hijack a DotNetNuke server via a single script injection

Over 750,000 websites require patching following discovery of DotNetNuke XSS vulnerability ...
FierceBiotech

Boehringer hands over funding, marketing rights for Click’s digital therapeutic

Boehringer Ingelheim and Click Therapeutics are restructuring their marketing deal for the software-based schizophrenia treatment CT-155, as the German pharma also opens its coffers. Under what the ...